New Osteoarthritis Treatment Agent
Osteoarthritis
Partnership StageSales partnership announced Dec 2025
Key Facts
Indication
Osteoarthritis
Phase
Partnership Stage
Status
Sales partnership announced Dec 2025
Company
About Teikoku Seiyaku
A 170-year-old Japanese pioneer in transdermal hydrogel patches, developing innovative pain management and systemic drug delivery solutions.
View full company profileTherapeutic Areas
Other Osteoarthritis Drugs
| Drug | Company | Phase |
|---|---|---|
| MSC‑OA | Advancells | Phase 1 |
| Osteoarthritis program | Risen Pharma Tech | Clinical (China & US) |
| ViscoCell™ for Osteoarthritis | Likarda | Pre-clinical |
| Osteoarthritis Biologic Therapy | Ageless Biotech | Phase 2b |
| PKM-011 | PK MED | Pre-clinical |
| CYT-108 | Cytonics | Phase 2 |
| Topical PSGAG | ADORA Life Science | Pre-clinical |
| FGF18 Gene Therapy | Remedium Bio | Pre-clinical |
| MOTYS™ | Doron Therapeutics | Phase 3 |
| Osteoarthritis Treatment Program | Biovico | Pre-clinical |
| aGF | Scarcell Therapeutics | Phase 1 |
| Cartilage Repair | Sayenza Biosciences | Clinical |